$BAH

Why is Booz Allen Hamilton stock rallying today?

Booz Allen Hamilton (BAH) stock rose 3.7% after TD Cowen upgraded it to Buy with a $95 price target, citing growth in funded backlog and improving sales trends. UBS and Citi also raised price targets, while BofA Securities cut its target to $68. The company reported strong Q2 2027 earnings and raised full-year EPS guidance. The S&P 500, Dow Jones, and Nasdaq were up 0.4%, 0.4%, and 0.3% respectively in morning trading.

Original reporting
Published Oct 26, 2026, 1:59 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 2:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$BAH
Bullish
high confidence
Mentioned
$BAH
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BAHBullishHigh
01

Why it matters

The upgrades provide fresh bullish catalysts, reinforcing the stock's upward momentum.

02

Market read

The combined analyst upgrades and earnings beat drove a 3.7% pre‑market rally, making BAH a short‑term buying opportunity.

03

What to watch

Backlog growth and fixed‑price contracts could sustain margins beyond the short‑term rally.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

The article reports analyst upgrades and price‑target revisions following Booz Allen Hamilton's recent earnings beat and guidance raise.

Company-level read

Ticker impact

$BAHBullishHigh confidence
Context

TD Cowen upgraded Booz Allen Hamilton to Buy and raised its price target to $95, driving a 3.7% rally in pre‑market trading.

Expected impact

likely upward pressure as investors price in the upgraded rating and higher targets

Evidence & confidence

Multiple brokerages raised targets today; the stock already moved up 3.7% on the news, indicating strong buying interest.

Market effects

Positive sentiment may spill over to other government‑consulting peers.

U.S. market modestly supported by the rally in a defense‑related stock.

Limited to U.S. equities; no broader macro impact.

Counterpoint

BofA cut its target to $68, citing earnings boost from tax benefits rather than operational strength.

Key entities

  • TD Cowen

    Upgraded BAH to Buy and raised target to $95.

  • UBS

    Raised target to $86, maintaining Neutral.

  • Citi

    Lifted target to $88, maintaining Neutral.

Related articles

$BAHHigh

Booz Allen Jumped 7% as TD Cowen Upgrades to Buy on Improving Backlog

Booz Allen Hamilton (BAH) shares rose 7% after TD Cowen upgraded the stock to Buy and raised its price target to $95. The company's funded backlog increased 5% to $5.7 billion, while revenue fell 4%. BAH also raised its fiscal 2027 adjusted EPS guidance to $6.50-$6.70. Analysts cited improving backlog as a positive sign despite falling revenue.

$BAHHighAI 8/10

Why Booz Allen Hamilton (BAH) stock is up today

Booz Allen Hamilton (BAH) stock rose 7.8% after reporting Q2 adjusted earnings of $1.76/share, above estimates, and raising full-year guidance. Revenue was $2.78B, slightly below expectations. Management cited profit growth and a large classified award for the results. The company expects fiscal 2027 revenue of $11.3B to $11.6B and adjusted earnings of $6.50 to $6.70/share.